Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Mar 15;101(6):1334–1341. doi: 10.1172/JCI610

Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line.

S A Beak 1, M M Heath 1, C J Small 1, D G Morgan 1, M A Ghatei 1, A D Taylor 1, J C Buckingham 1, S R Bloom 1, D M Smith 1
PMCID: PMC508688  PMID: 9502775

Abstract

To examine the influence of the putative satiety factor (GLP-1) on the hypothalamo-pituitary-gonadal axis, we used GT1-7 cells as a model of neuronal luteinizing hormone- releasing hormone (LHRH) release. GLP-1 caused a concentration-dependent increase in LHRH release from GT1-7 cells. Specific, saturable GLP-1 binding sites were demonstrated on these cells. The binding of [125I]GLP-1 was time-dependent and consistent with a single binding site (Kd = 0.07+/-0.016 nM; binding capacity = 160+/-11 fmol/mg protein). The specific GLP-1 receptor agonists, exendin-3 and exendin-4, also showed high affinity (Ki = 0.3+/-0.05 and 0.32+/-0.06 nM, respectively) as did the antagonist exendin-(9-39) (Ki = 0.98+/-0.24 nM). At concentrations that increased LHRH release, GLP-1 (0.5-10 nM) also caused an increase in intracellular cAMP in GT1-7 cells (10 nM GLP-1: 7.66+/-0.4 vs. control: 0.23+/-0.02 nmol/mg protein; P < 0.001). Intracerebroventricular injection of GLP-1 at a single concentration (10 microg) produced a prompt increase in the plasma luteinizing hormone concentration in male rats (GLP-1: 1.09+/-0.11 vs. saline: 0.69+/-0.06 ng/ml; P < 0.005). GLP-1 levels in the hypothalami of 48-h-fasted male rats showed a decrease, indicating a possible association of the satiety factor with the low luteinizing hormone levels in animals with a negative energy balance.

Full Text

The Full Text of this article is available as a PDF (208.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvarez E., Roncero I., Chowen J. A., Thorens B., Blázquez E. Expression of the glucagon-like peptide-1 receptor gene in rat brain. J Neurochem. 1996 Mar;66(3):920–927. doi: 10.1046/j.1471-4159.1996.66030920.x. [DOI] [PubMed] [Google Scholar]
  2. Barash I. A., Cheung C. C., Weigle D. S., Ren H., Kabigting E. B., Kuijper J. L., Clifton D. K., Steiner R. A. Leptin is a metabolic signal to the reproductive system. Endocrinology. 1996 Jul;137(7):3144–3147. doi: 10.1210/endo.137.7.8770941. [DOI] [PubMed] [Google Scholar]
  3. Beak S. A., Small C. J., Ilovaiskaia I., Hurley J. D., Ghatei M. A., Bloom S. R., Smith D. M. Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on alpha-TSH cells. Endocrinology. 1996 Oct;137(10):4130–4138. doi: 10.1210/endo.137.10.8828468. [DOI] [PubMed] [Google Scholar]
  4. Besecke L. M., Wolfe A. M., Pierce M. E., Takahashi J. S., Levine J. E. Neuropeptide Y stimulates luteinizing hormone-releasing hormone release from superfused hypothalamic GT1-7 cells. Endocrinology. 1994 Oct;135(4):1621–1627. doi: 10.1210/endo.135.4.7925125. [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  6. Cagampang F. R., Maeda K., Yokoyama A., Ota K. Effect of food deprivation on the pulsatile LH release in the cycling and ovariectomized female rat. Horm Metab Res. 1990 May;22(5):269–272. doi: 10.1055/s-2007-1004900. [DOI] [PubMed] [Google Scholar]
  7. Calvo J. C., Yusta B., Mora F., Blázquez E. Structural characterization by affinity cross-linking of glucagon-like peptide-1(7-36)amide receptor in rat brain. J Neurochem. 1995 Jan;64(1):299–306. doi: 10.1046/j.1471-4159.1995.64010299.x. [DOI] [PubMed] [Google Scholar]
  8. Cameron J. L., Nosbisch C. Suppression of pulsatile luteinizing hormone and testosterone secretion during short term food restriction in the adult male rhesus monkey (Macaca mulatta). Endocrinology. 1991 Mar;128(3):1532–1540. doi: 10.1210/endo-128-3-1532. [DOI] [PubMed] [Google Scholar]
  9. Chehab F. F., Lim M. E., Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 1996 Mar;12(3):318–320. doi: 10.1038/ng0396-318. [DOI] [PubMed] [Google Scholar]
  10. Eng J., Kleinman W. A., Singh L., Singh G., Raufman J. P. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem. 1992 Apr 15;267(11):7402–7405. [PubMed] [Google Scholar]
  11. Fehmann H. C., Göke R., Göke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev. 1995 Jun;16(3):390–410. doi: 10.1210/edrv-16-3-390. [DOI] [PubMed] [Google Scholar]
  12. Griffin M. L., South S. A., Yankov V. I., Booth R. A., Jr, Asplin C. M., Veldhuis J. D., Evans W. S. Insulin-dependent diabetes mellitus and menstrual dysfunction. Ann Med. 1994 Oct;26(5):331–340. doi: 10.3109/07853899409148347. [DOI] [PubMed] [Google Scholar]
  13. Gros L., Thorens B., Bataille D., Kervran A. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line. Endocrinology. 1993 Aug;133(2):631–638. doi: 10.1210/endo.133.2.8102095. [DOI] [PubMed] [Google Scholar]
  14. Göke R., Conlon J. M. Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells. J Endocrinol. 1988 Mar;116(3):357–362. doi: 10.1677/joe.0.1160357. [DOI] [PubMed] [Google Scholar]
  15. Göke R., Fehmann H. C., Linn T., Schmidt H., Krause M., Eng J., Göke B. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem. 1993 Sep 15;268(26):19650–19655. [PubMed] [Google Scholar]
  16. Göke R., Larsen P. J., Mikkelsen J. D., Sheikh S. P. Identification of specific binding sites for glucagon-like peptide-1 on the posterior lobe of the rat pituitary. Neuroendocrinology. 1995 Aug;62(2):130–134. doi: 10.1159/000126997. [DOI] [PubMed] [Google Scholar]
  17. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  18. Jin S. L., Han V. K., Simmons J. G., Towle A. C., Lauder J. M., Lund P. K. Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol. 1988 May 22;271(4):519–532. doi: 10.1002/cne.902710405. [DOI] [PubMed] [Google Scholar]
  19. Kalra S. P., Crowley W. R. Norepinephrine-like effects of neuropeptide Y on LH release in the rat. Life Sci. 1984 Sep 10;35(11):1173–1176. doi: 10.1016/0024-3205(84)90187-5. [DOI] [PubMed] [Google Scholar]
  20. Kalra S. P., Kalra P. S. Nutritional infertility: the role of the interconnected hypothalamic neuropeptide Y-galanin-opioid network. Front Neuroendocrinol. 1996 Oct;17(4):371–401. doi: 10.1006/frne.1996.0010. [DOI] [PubMed] [Google Scholar]
  21. Kanse S. M., Kreymann B., Ghatei M. A., Bloom S. R. Identification and characterization of glucagon-like peptide-1 7-36 amide-binding sites in the rat brain and lung. FEBS Lett. 1988 Dec 5;241(1-2):209–212. doi: 10.1016/0014-5793(88)81063-9. [DOI] [PubMed] [Google Scholar]
  22. Kreymann B., Ghatei M. A., Burnet P., Williams G., Kanse S., Diani A. R., Bloom S. R. Characterization of glucagon-like peptide-1-(7-36)amide in the hypothalamus. Brain Res. 1989 Nov 20;502(2):325–331. doi: 10.1016/0006-8993(89)90628-8. [DOI] [PubMed] [Google Scholar]
  23. Kreymann B., Williams G., Ghatei M. A., Bloom S. R. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987 Dec 5;2(8571):1300–1304. doi: 10.1016/s0140-6736(87)91194-9. [DOI] [PubMed] [Google Scholar]
  24. Kreymann B., Yiangou Y., Kanse S., Williams G., Ghatei M. A., Bloom S. R. Isolation and characterisation of GLP-1 7-36 amide from rat intestine. Elevated levels in diabetic rats. FEBS Lett. 1988 Dec 19;242(1):167–170. doi: 10.1016/0014-5793(88)81008-1. [DOI] [PubMed] [Google Scholar]
  25. Larsen P. J., Tang-Christensen M., Holst J. J., Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience. 1997 Mar;77(1):257–270. doi: 10.1016/s0306-4522(96)00434-4. [DOI] [PubMed] [Google Scholar]
  26. Leibowitz S. F. Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trends Neurosci. 1992 Dec;15(12):491–497. doi: 10.1016/0166-2236(92)90101-d. [DOI] [PubMed] [Google Scholar]
  27. Leposavic G., Dashwood M. R., Ginsburg J., Buckingham J. C. Peripubertal changes in the nature of the GnRH response to alpha-adrenoceptor stimulation in vitro and their modulation by testosterone. Neuroendocrinology. 1990 Jul;52(1):82–89. doi: 10.1159/000125543. [DOI] [PubMed] [Google Scholar]
  28. Mellon P. L., Windle J. J., Goldsmith P. C., Padula C. A., Roberts J. L., Weiner R. I. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron. 1990 Jul;5(1):1–10. doi: 10.1016/0896-6273(90)90028-e. [DOI] [PubMed] [Google Scholar]
  29. Merchenthaler I., Görcs T., Sétáló G., Petrusz P., Flerkó B. Gonadotropin-releasing hormone (GnRH) neurons and pathways in the rat brain. Cell Tissue Res. 1984;237(1):15–29. doi: 10.1007/BF00229195. [DOI] [PubMed] [Google Scholar]
  30. Mojsov S., Heinrich G., Wilson I. B., Ravazzola M., Orci L., Habener J. F. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem. 1986 Sep 5;261(25):11880–11889. [PubMed] [Google Scholar]
  31. Morgan D. G., Lambert P. D., Smith D. M., Wilding J. P., Bloom S. R. Reduced NPY induced feeding in diabetic but not steroid-treated rats: lack of evidence for changes in receptor number or affinity. J Neuroendocrinol. 1996 Apr;8(4):283–290. doi: 10.1046/j.1365-2826.1996.04565.x. [DOI] [PubMed] [Google Scholar]
  32. Schepp W., Schmidtler J., Riedel T., Dehne K., Schusdziarra V., Holst J. J., Eng J., Raufman J. P., Classen M. Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2. Eur J Pharmacol. 1994 Oct 14;269(2):183–191. doi: 10.1016/0922-4106(94)90085-x. [DOI] [PubMed] [Google Scholar]
  33. Schreihofer D. A., Amico J. A., Cameron J. L. Reversal of fasting-induced suppression of luteinizing hormone (LH) secretion in male rhesus monkeys by intragastric nutrient infusion: evidence for rapid stimulation of LH by nutritional signals. Endocrinology. 1993 May;132(5):1890–1897. doi: 10.1210/endo.132.5.8477642. [DOI] [PubMed] [Google Scholar]
  34. Shimizu I., Hirota M., Ohboshi C., Shima K. Identification and localization of glucagon-like peptide-1 and its receptor in rat brain. Endocrinology. 1987 Sep;121(3):1076–1082. doi: 10.1210/endo-121-3-1076. [DOI] [PubMed] [Google Scholar]
  35. Shughrue P. J., Lane M. V., Merchenthaler I. Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology. 1996 Nov;137(11):5159–5162. doi: 10.1210/endo.137.11.8895391. [DOI] [PubMed] [Google Scholar]
  36. Stewart D. E. Reproductive functions in eating disorders. Ann Med. 1992 Aug;24(4):287–291. doi: 10.3109/07853899209149956. [DOI] [PubMed] [Google Scholar]
  37. Tang-Christensen M., Larsen P. J., Göke R., Fink-Jensen A., Jessop D. S., Møller M., Sheikh S. P. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol. 1996 Oct;271(4 Pt 2):R848–R856. doi: 10.1152/ajpregu.1996.271.4.R848. [DOI] [PubMed] [Google Scholar]
  38. Thorens B., Porret A., Bühler L., Deng S. P., Morel P., Widmann C. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes. 1993 Nov;42(11):1678–1682. doi: 10.2337/diab.42.11.1678. [DOI] [PubMed] [Google Scholar]
  39. Turton M. D., O'Shea D., Gunn I., Beak S. A., Edwards C. M., Meeran K., Choi S. J., Taylor G. M., Heath M. M., Lambert P. D. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 1996 Jan 4;379(6560):69–72. doi: 10.1038/379069a0. [DOI] [PubMed] [Google Scholar]
  40. Uttenthal L. O., Blázquez E. Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands. FEBS Lett. 1990 Mar 12;262(1):139–141. doi: 10.1016/0014-5793(90)80173-g. [DOI] [PubMed] [Google Scholar]
  41. Van der Spuy Z. M. Nutrition and reproduction. Clin Obstet Gynaecol. 1985 Sep;12(3):579–604. [PubMed] [Google Scholar]
  42. Wheeler M. B., Lu M., Dillon J. S., Leng X. H., Chen C., Boyd A. E., 3rd Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology. 1993 Jul;133(1):57–62. doi: 10.1210/endo.133.1.8391428. [DOI] [PubMed] [Google Scholar]
  43. Widmann C., Bürki E., Dolci W., Thorens B. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines. Mol Pharmacol. 1994 May;45(5):1029–1035. [PubMed] [Google Scholar]
  44. Yoshimoto S., Hirota M., Ohboshi C., Shima K. Identification of glucagon-like peptide-1(7-36) amide in rat brain. Ann Clin Biochem. 1989 Mar;26(Pt 2):169–171. doi: 10.1177/000456328902600214. [DOI] [PubMed] [Google Scholar]
  45. Yu W. H., Kimura M., Walczewska A., Karanth S., McCann S. M. Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):1023–1028. doi: 10.1073/pnas.94.3.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Zamani M. R., Bristow D. R. The histamine H1 receptor in GT1-7 neuronal cells is regulated by calcium influx and KN-62, a putative inhibitor of calcium/calmodulin protein kinase II. Br J Pharmacol. 1996 Jul;118(5):1119–1126. doi: 10.1111/j.1476-5381.1996.tb15514.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. van Eyll B., Lankat-Buttgereit B., Bode H. P., Göke R., Göke B. Signal transduction of the GLP-1-receptor cloned from a human insulinoma. FEBS Lett. 1994 Jul 4;348(1):7–13. doi: 10.1016/0014-5793(94)00553-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES